Literature DB >> 14618488

Body composition modification in obese patients treated with intragastric balloon.

M G Carbonelli1, M A Fusco, F Cannistrà, A Andreoli, A De Lorenzo.   

Abstract

At the Centre for the Therapy of Morbid Obesity, a multidisciplinary team attends severely obese patients in a day-care hospital setting. The patients' psychological and nutritional profiles are studied and their body composition investigated with bioelectrical impedance. After the diagnosis, several approaches are proposed; among them, the insertion of a Bioenterics Intragastric Balloon (BIB). For 6 months after insertion, patients were periodically examined and followed a strict personal regimen, behaviour schedule and physical activity programme compatible with the BIB. The results obtained from the first 20 subjects are encouraging. No severe complications have been reported, and after the BIB removal, subjects are maintaining the obtained results with some of them continuing to lose weight.

Entities:  

Mesh:

Year:  2003        PMID: 14618488     DOI: 10.1007/s00592-003-0081-3

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

Review 1.  Evidence-based review of the Bioenterics intragastric balloon for weight loss.

Authors:  Jean-Marc Dumonceau
Journal:  Obes Surg       Date:  2008-06-21       Impact factor: 4.129

Review 2.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

3.  Five percent weight lost in the first month of intragastric balloon treatment may be a predictor for long-term weight maintenance.

Authors:  Umit Bilge Dogan; Yuksel Gumurdulu; Mustafa Salih Akin; Serkan Yalaki
Journal:  Obes Surg       Date:  2013-07       Impact factor: 4.129

4.  Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome.

Authors:  Erika P Guedes; Eduardo Madeira; Thiago T Mafort; Miguel Madeira; Rodrigo O Moreira; Laura Maria C Mendonça; Amélio F Godoy-Matos; Agnaldo J Lopes; Maria Lucia F Farias
Journal:  Diabetol Metab Syndr       Date:  2016-12-19       Impact factor: 3.320

5.  Development and Testing of a Magnetically Actuated Capsule Endoscopy for Obesity Treatment.

Authors:  Thanh Nho Do; Tian En Timothy Seah; Khek Yu Ho; Ho Khek Yu; Soo Jay Phee
Journal:  PLoS One       Date:  2016-01-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.